Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2014 3
2016 2
2017 4
2018 7
2019 5
2020 13
2021 14
2022 16
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study.
Tromp TR, Hartgers ML, Hovingh GK, Vallejo-Vaz AJ, Ray KK, Soran H, Freiberger T, Bertolini S, Harada-Shiba M, Blom DJ, Raal FJ, Cuchel M; Homozygous Familial Hypercholesterolaemia International Clinical Collaborators. Tromp TR, et al. Lancet. 2022 Feb 19;399(10326):719-728. doi: 10.1016/S0140-6736(21)02001-8. Epub 2022 Jan 28. Lancet. 2022. PMID: 35101175 Free PMC article.
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group. Marso SP, et al. N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605603 Free PMC article. Clinical Trial.
ANGPTL3 Deficiency and Risk of Hepatic Steatosis.
D'Erasmo L, Di Martino M, Neufeld T, Fraum TJ, Kang CJ, Burks KH, Di Costanzo A, Minicocci I, Bini S, Maranghi M, Pigna G, Labbadia G, Zheng J, Fierro D, Montali A, Ceci F, Catalano C, Davidson NO, Lucisano G, Nicolucci A, Arca M, Stitziel NO. D'Erasmo L, et al. Circulation. 2023 Nov 7;148(19):1479-1489. doi: 10.1161/CIRCULATIONAHA.123.065866. Epub 2023 Sep 15. Circulation. 2023. PMID: 37712257
Recent Apolipoprotein CIII trials.
Tramontano D, Bini S, D'Erasmo L, Arca M. Tramontano D, et al. Among authors: d erasmo l. Curr Opin Lipidol. 2022 Dec 1;33(6):309-318. doi: 10.1097/MOL.0000000000000849. Epub 2022 Sep 28. Curr Opin Lipidol. 2022. PMID: 36206093 Review.
New and Emerging Therapies for Dyslipidemia.
Zambon A, Averna M, D'Erasmo L, Arca M, Catapano A. Zambon A, et al. Among authors: d erasmo l. Endocrinol Metab Clin North Am. 2022 Sep;51(3):635-653. doi: 10.1016/j.ecl.2022.02.004. Epub 2022 Jul 10. Endocrinol Metab Clin North Am. 2022. PMID: 35963633 Review.
How ANGPTL3 Inhibition Will Help Our Clinical Practice?
Bini S, Tramontano D, Minicocci I, Di Costanzo A, Tambaro F, D'Erasmo L, Arca M. Bini S, et al. Among authors: d erasmo l. Curr Atheroscler Rep. 2023 Jan;25(1):19-29. doi: 10.1007/s11883-022-01076-w. Epub 2023 Jan 6. Curr Atheroscler Rep. 2023. PMID: 36607583 Review.
70 results